Even though physicians have a proven medication at their disposal to prevent the spread of HIV among high-risk populations, the disease continues to flare up.
A new study from Oregon Health & Science University delves into why clinicians are not prescribing PrEP, or pre-exposure prophylaxis, as much as they could be. The Food and Drug Administration approved the drug about seven years ago.
Dr. Chris Terndrup, an assistant professor of medicine at OHSU, partnered with researchers at five academic…
